Australia's most trusted
source of pharma news
Thursday, 18 April 2024
Posted 20 January 2022 PM
After a long, trouble-plagued journey, Novavax's COVID-19 vaccine Nuvaxovid has finally received provisional approval from the TGA - but don't expect a rush on uptake, with the authorisation only for primary vaccination in adults, not boosters.
As of 19 January, over 95 per cent of Australians over the age of 16 had received at least one dose, and 92.7 per cent of Australians over the age of 16 are fully vaccinated, according to the Department of Health.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.